mechanisms of CKD progression
pathophysiology of CKD
diagnosis of CKD
Chronic Kidney Disease progression
worldwide incidence of CKD
use of SEMA3C
disease spectrum
human Chronic Kidney Disease
NRP1 signalling pathway
renal injury
prealbuminuric stages of paediatric CKD patients
receptor NRP1
secreted glycoprotein SEMA3C
mouse models of kidney injury
new signalling events
renal parenchyma
Renal fibrosis
new directions
early stages
extracellular matrix
mice deficient
current understanding
engineered mice
deposition of pathological matrix
improved mechanistic understanding
initial insult
production
Neuropilin
microvasculature rearrangement
pharmaceutical interventions
cutting-edge technologies
common end point of CKDs
development of novel treatments
cellular morphology
order
potential biomarker
guidance proteins
epidemic proportions
important roles
hallmark
progressive destruction
cells
levels
loss of functional nephrons
medical planning
major objectives
key challenge
Semaphorins
myofibroblasts
organogenesis
Genetic dissection
adult population
work